Abstract
Over 71 million people are living with hepatitis C virus (HCV) globally. HCV is an RNA virus that can be classified into different types of genotypes and can lead to multiple complications, including liver cirrhosis, hepatocellular carcinoma, and death. HCV treatments are effective but highly dependent on the HCV genotype and subtype. There are few studies describing the HCV genotype in the Middle East, in particular, Saudi Arabia. This study aims to describe the genotypes of patients with HCV living in Saudi Arabia and their associated treatments.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
